Display options
Share it on

FEBS Open Bio. 2016 Nov 07;6(12):1170-1177. doi: 10.1002/2211-5463.12132. eCollection 2016 Dec.

The structure of Toho1 β-lactamase in complex with penicillin reveals the role of Tyr105 in substrate recognition.

FEBS open bio

Patricia S Langan, Venu Gopal Vandavasi, Kevin L Weiss, Jonathan B Cooper, Stephan L Ginell, Leighton Coates

Affiliations

  1. Biology and Soft Matter Division Oak Ridge National Laboratory TN USA.
  2. Birkbeck University of London UK.
  3. Structural Biology Center Argonne National Laboratory IL USA.

PMID: 28255534 PMCID: PMC5324766 DOI: 10.1002/2211-5463.12132

Abstract

The role of the conserved residue Tyr105 in class A β-lactamases has been the subject of investigation using both structural studies and saturation mutagenesis. Both have shown that while it does not need to be strictly conserved for activity, it is important for substrate recognition. With this in mind we determined the crystal structure of Toho1 β-lactamase at 15 K to 1.10 Å resolution in complex with penicillin. As expected a ring-opened penicillin molecule bound to Ser70 the catalytic nucleophile, can clearly be seen in electron density in the active site. In addition to the trapped penicillin, however, are two additional intact ring-closed penicillin molecules, captured by the enzyme through noncovalent interactions at the edge of the active site.

Keywords: X‐ray crystallography; antibiotic resistance; antibiotics; enzyme; enzyme structure

References

  1. Methods Mol Biol. 2009;544:281-92 - PubMed
  2. Biochemistry. 1994 Jun 21;33(24):7619-26 - PubMed
  3. Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501 - PubMed
  4. J Biol Chem. 2002 Nov 29;277(48):46601-8 - PubMed
  5. J Mol Biol. 2010 Mar 5;396(4):1070-80 - PubMed
  6. Biochim Biophys Acta. 2010 Apr;1804(4):684-91 - PubMed
  7. Nat Struct Biol. 1996 Aug;3(8):688-95 - PubMed
  8. FEBS Lett. 2011 Jan 21;585(2):364-8 - PubMed
  9. Int J Antimicrob Agents. 2000 Mar;14(2):137-42 - PubMed
  10. Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42 - PubMed
  11. Biochem J. 1998 Mar 1;330 ( Pt 2):581-98 - PubMed
  12. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Apr 1;65(Pt 4):379-82 - PubMed
  13. Biochem J. 1991 May 15;276 ( Pt 1):269-70 - PubMed
  14. Biochemistry. 2004 Jul 13;43(27):8744-53 - PubMed
  15. Chem Rev. 2005 Feb;105(2):395-424 - PubMed
  16. J Biol Chem. 2013 Feb 15;288(7):4715-22 - PubMed
  17. J Antimicrob Chemother. 1995 Jan;35(1):7-22 - PubMed
  18. Nat Prod Rep. 1999 Feb;16(1):1-19 - PubMed
  19. Clin Microbiol Rev. 2010 Jan;23(1):160-201 - PubMed
  20. J Biol Chem. 2004 Oct 29;279(44):46295-303 - PubMed
  21. Nat Struct Biol. 1996 Mar;3(3):290-7 - PubMed
  22. Antimicrob Agents Chemother. 2004 Jan;48(1):1-14 - PubMed
  23. J Med Chem. 2016 Jan 14;59(1):474-9 - PubMed
  24. Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33 - PubMed
  25. Antimicrob Agents Chemother. 1995 Dec;39(12):2593-601 - PubMed
  26. Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22 - PubMed
  27. Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32 - PubMed
  28. Protein Eng. 1995 Feb;8(2):127-34 - PubMed

Publication Types